Successful Australian civil construction entity, State Road Constructions (“State Road”), has selected the Intelligent Fingerprinting Drug Screening System as its
The true competitive edge for any organization is its people. At the core of every thriving business lies a commitment
The Intelligent Fingerprinting Drug Screening System is quick and easy to use, detecting commonly abused drugs via sweat from the fingertips. Sample collection takes less than a minute using the Intelligent Fingerprinting Drug Screening Cartridge, and results are available within ten minutes using the Intelligent Fingerprinting Drug Screening Reader. The System’s ease of use and…
Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions,
The International Mining and Resources Conference (IMARC) hosted in Sydney, Australia, last week was a great success for Intelligent Bio
We are delighted to announce our expansion into New Zealand and observe another key growth milestone. Our primary focus is
The cost of drug use in the workplace is a significant concern for employers, employees, and society as a whole.
Intelligent Bio Solutions Inc. today announced the adoption of its Intelligent Fingerprinting Drug Screening System by specialist container logistics firm,
Intelligent Bio Solutions today announced the closing of its previously announced underwritten public offering of units for gross proceeds of
Intelligent Bio Solutions announces the pricing of an underwritten public offering of units for gross proceeds of approximately $4.0 million.
International certification adds to Quality Management Systems credentials for the medical device industry and supports expansion plans into North America
The Workplace Health & Safety Show is Australia’s only workplace health and safety event, with thousands of health and safety
New assays for ketamine and tramadol testing pass initial Intelligent Fingerprinting design phase and begin next stage of transfer to
Intelligent Bio Solutions Inc. today announced its financial results for its fiscal third quarter ended March 31, 2023, and provided
Since the Company’s entry into the Australian market with its Intelligent Fingerprinting Drug Screening System, the dedicated efforts of the
